학술논문
RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer
Document Type
Artikel
Author
Source
Clinical breast cancer. 17(8):585
Subject
Language
English
English
English
ISSN
1938-0666